ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Veracyte Inc

Veracyte Inc (VCYT)

33.01
-6.35
( -16.13% )
Actualizado: 11:27:44
Gráfico avanzado

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
33.01
Postura de Compra
32.95
Postura de Venta
33.03
Volume Operado de la Acción
1,406,318
32.67 Rango del Día 38.7854
18.61 Rango de 52 semanas 47.3162
Capitalización de Mercado [m]
Precio Anterior
39.36
Precio de Apertura
36.10
Última hora de negociación
11:27:44
Volumen financiero
US$ 48,315,938
Precio Promedio Ponderado
34.3563
Volumen promedio (3 m)
749,927
Acciones en circulación
77,499,629
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-34.30
Beneficio por acción (BPA)
-0.96
turnover
361.05M
Beneficio neto
-74.4M

Acerca de Veracyte Inc

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, En... Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis product. Mostrar más

Sector
Medical Laboratories
Industria
Medical Laboratories
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Veracyte Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker VCYT. The last closing price for Veracyte was US$39.36. Over the last year, Veracyte shares have traded in a share price range of US$ 18.61 to US$ 47.3162.

Veracyte currently has 77,499,629 shares in issue. The market capitalisation of Veracyte is US$3.05 billion. Veracyte has a price to earnings ratio (PE ratio) of -34.30.

VCYT Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-9.211-21.816157836142.22142.3432.6779322840.32257727CS
4-10.19-23.58796296343.247.316232.6775456142.23526379CS
12-10.36-23.887479824843.3747.316232.6774992742.11458176CS
260.581.7884674683932.4347.316228.4476816237.99376202CS
5211.1350.868372943321.8847.316218.6179448230.26917945CS
1566.4224.144415193726.5947.316214.8578648725.73490891CS
2609.0337.656380316923.9886.0313.973932631.52749284CS

VCYT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Veracyte?
El precio actual de las acciones de Veracyte es US$ 33.01
¿Cuántas acciones de Veracyte están en circulación?
Veracyte tiene 77,499,629 acciones en circulación
¿Cuál es la capitalización de mercado de Veracyte?
La capitalización de mercado de Veracyte es USD 3.05B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Veracyte?
Veracyte ha negociado en un rango de US$ 18.61 a US$ 47.3162 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Veracyte?
El ratio precio/beneficio de Veracyte es -34.3
¿Cuál es el ratio de efectivo a ventas de Veracyte?
El ratio de efectivo a ventas de Veracyte es 7.07
¿Cuál es la moneda de reporte de Veracyte?
Veracyte presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Veracyte?
El último ingresos anual de Veracyte es USD 361.05M
¿Cuál es el último beneficio anual de Veracyte?
El último beneficio anual de Veracyte es USD -74.4M
¿Cuál es la dirección registrada de Veracyte?
La dirección registrada de Veracyte es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Veracyte?
La dirección del sitio web de Veracyte es www.veracyte.com
¿En qué sector industrial opera Veracyte?
Veracyte opera en el sector MEDICAL LABORATORIES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ONVOOrganovo Holdings Inc
US$ 1.55
(320.05%)
283.44M
WAFUWah Fu Education Group Ltd
US$ 3.3399
(86.59%)
106.54M
MFImF International Ltd
US$ 0.9709
(61.90%)
62.48M
FMTOFemto Technologies Inc
US$ 5.65
(57.97%)
36M
SLXNSilexion Therapeutics Corporation
US$ 1.165
(55.33%)
81.07M
SXTCChina SXT Pharmaceuticals Inc
US$ 3.9564
(-41.13%)
570.58k
RNAZTransCode Therapeutics Inc
US$ 4.10
(-39.53%)
331.67k
YYAIConnexa Sports Technologies Inc
US$ 0.7771
(-38.81%)
4.53M
DGNXDiginex Ltd
US$ 48.22
(-30.46%)
232.18k
BTDRBitdeer Technologies Group
US$ 9.25
(-29.39%)
11.56M
ONVOOrganovo Holdings Inc
US$ 1.5338
(315.66%)
283.48M
NVDANVIDIA Corporation
US$ 127.8301
(-1.88%)
148.02M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 14.39
(-16.96%)
113.55M
WAFUWah Fu Education Group Ltd
US$ 3.3399
(86.59%)
106.54M
PLTRPalantir Technologies Inc
US$ 87.16
(-3.88%)
86.42M

VCYT Finanzas

Finanzas

VCYT Discussion

Ver más
Monksdream Monksdream 2 días hace
VCYT! 10Q due MONDAY 2/24

👍️0
Monksdream Monksdream 9 meses hace
VCYT under $20 a buy
👍️0
allisondbl allisondbl 4 años hace
Anyone got any idea what's going on with this in the last two days?? Only good news and it's down HUGELY??
👍️0
stocktrademan stocktrademan 6 años hace
VCYT buy 23.8101



normal chart







log chart






👍️0
Alan Brown Alan Brown 6 años hace
Yep....
👍️0
ClayTrader ClayTrader 6 años hace
* * $VCYT Video Chart 10-31-18 * *

Link to Video - click here to watch the technical chart video

👍️0
stocktrademan stocktrademan 9 años hace
$VCYT recent news/filings

bearish 4.76

## source: finance.yahoo.com

$VCYT charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$VCYT company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/VCYT/company-info
Ticker: $VCYT
OTC Market Place: Not Available
CIK code: not found
Company name: Veracyte Inc.
Incorporated In:
$VCYT share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$VCYT extra dd links

Company name: Veracyte Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VCYT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VCYT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VCYT+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VCYT/news - http://finance.yahoo.com/q/h?s=VCYT+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VCYT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VCYT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VCYT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VCYT
DTCC (dtcc.com): http://search2.dtcc.com/?q=Veracyte+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Veracyte+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Veracyte+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VCYT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VCYT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VCYT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VCYT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VCYT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VCYT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VCYT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VCYT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VCYT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VCYT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VCYT+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VCYT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VCYT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VCYT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VCYT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VCYT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VCYT/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VCYT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VCYT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VCYT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VCYT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VCYT



$VCYT DD Notes ~ http://www.ddnotesmaker.com/VCYT
👍️0
gumibear gumibear 10 años hace
Hey. Anyone following this stock? I've been averaging down from 14s to 7s and wondering when it will show some reversal.
👍️0
Gixene Gixene 11 años hace
starbuxsux, thanks for sharing.
👍️0
starbuxsux starbuxsux 11 años hace
Veracyte, Inc. Announces Closing of Initial Public Offering

4:26 PM ET 11/4/13 | PR Newswire

Veracyte, Inc. (Nasdaq: VCYT) announced today the closing of its initial public offering of 5,000,000 shares of its common stock resulting in net proceeds of approximately $58.0 million after deducting underwriting discounts and commissions and estimated expenses. All of the shares of common stock were offered by Veracyte at a price to the public of $13.00 per share.

Morgan Stanley and Leerink Swann acted as joint book-running managers for the offering. William Blair and Cowen and Company acted as co-managers.

A copy of the final prospectus relating to the offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, New York, NY 10014, telephone: 1-866-718-1649, or email: prospectus@morganstanley.com; or Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, telephone: 1-800-808-7525 or email: Syndicate@Leerink.com.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 29, 2013. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of any such state or jurisdiction.

About Veracyte, Inc.

Veracyte is focused on discovering, developing and commercializing molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient care, thus helping patients avoid unnecessary invasive procedures while reducing healthcare costs. Veracyte's first commercial solution, the Afirma® Thyroid FNA Analysis, includes the Gene Expression Classifier (GEC). The GEC helps physicians reduce the number of unnecessary surgeries by employing a proprietary 142-gene signature to preoperatively determine whether thyroid nodules previously classified by cytopathology as indeterminate can be reclassified as benign. The clinical utility and cost effectiveness of the GEC have been demonstrated in studies published in peer-reviewed journals and the clinical validity of the GEC has been demonstrated in a study published in The New England Journal of Medicine in 2012. Since the commercial launch of Afirma in January 2011, Veracyte has processed over 50,000 fine needle aspiration (FNA) samples for evaluation using Afirma and has performed more than 10,000 GECs to resolve indeterminate cytopathology results. Veracyte has obtained positive coverage decisions for Afirma from Aetna, Humana, Medicare and UnitedHealthcare. Collectively, these payers represent more than 100 million covered lives. Afirma is marketed and sold in the United States through a global co-promotion agreement with Genzyme Corporation, a subsidiary of Sanofi.

Veracyte and Afirma are trademarks of Veracyte, Inc. This press release also contains trademarks and trade names that are the property of their respective owners.

Source: Veracyte

Media:Tracy Morris650-380-4413 Tracy.Morris@Veracyte.com

Investors:Angeli KolhatkarBurns McClellan, Inc.212-213-0006akolhatkar@burnsmc.com

SOURCE Veracyte

http://rt.prnewswire.com/rt.gif?NewsItemId=SF09897&Transmission_Id=201311041626PR_NEWS_USPR_____
👍️0
Gixene Gixene 11 años hace
New board.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock